Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1 (original) (raw)
Pantaleo G, Fauci AS . Immunopathogenesis of HIV infection. Annu Rev Microbiol 1996; 50: 825–854. ArticleCASPubMed Google Scholar
Verma IM, Somia N . Gene therapy – promises, problems and prospects. Nature 1997; 389: 239–242. ArticleCASPubMed Google Scholar
Buchschacher Jr GL, Wong-Staal F . Development of lentiviral vectors for gene therapy for human diseases. Blood 2000; 95: 2499–2504. CASPubMed Google Scholar
Chang L-J, Gay EE . The molecular genetics of lentiviral vectors – current and future perspectives. Curr Gene Ther 2001; 1: 237–251. ArticleCASPubMed Google Scholar
Akkina R et al. siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS. Anticancer Res 2003; 23: 1997–2005. CASPubMed Google Scholar
Elbashir SM et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494–498. ArticleCASPubMed Google Scholar
Qin X-F, An DS, Chen ISY, Baltimore D . Inhibition of HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 2002; 100: 183–188. ArticlePubMedPubMed Central Google Scholar
Butticaz C et al. Protection from HIV-1 infection of primary CD4T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression. Antivir Ther 2003; 8: 373–377. CASPubMed Google Scholar
Anderson J, Banerjea A, Planelles V, Akkina R . Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA. AIDS Res Hum Retroviruses 2003; 19: 699–706. ArticleCASPubMed Google Scholar
Ji J, Wernli M, Klimkait T, Erb P . Enhanced gene silencing by the application of multiple specific small interfering RNAs. FEBS Lett 2003; 552: 247–252. ArticleCASPubMed Google Scholar
Li MJ et al. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol Ther 2003; 8: 196–206. ArticleCASPubMed Google Scholar
Lee MT, Coburn GA, McClure MO, Cullen BR . Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol 2003; 77: 11964–11972. ArticleCASPubMedPubMed Central Google Scholar
Capodici J, Kariko K, Weissman D . Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J Immunol 2002; 169: 5196–5201. ArticlePubMed Google Scholar
Lee NS et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002; 20: 500–505. ArticleCASPubMed Google Scholar
Banerjea A et al. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol Ther 2003; 8: 62–71. ArticleCASPubMed Google Scholar
Park WS, Hayafune M, Miyano-Kurosaki N, Takaku H . Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells. Gene Therapy 2003; 10: 2046–2050. ArticleCASPubMed Google Scholar
McManus MT, Sharp PA . Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002; 3: 737–747. ArticleCASPubMed Google Scholar
Dykxhoorn DM, Novina CD, Sharp PA . Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 2003; 4: 457–467. ArticleCASPubMed Google Scholar
Tiscornia G, Singer O, Ikawa M, Verma IM . A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci USA 2003; 100: 1844–1848. ArticleCASPubMedPubMed Central Google Scholar
Rubinson DA et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003; 33: 401–406. ArticleCASPubMed Google Scholar
Reynolds A et al. Rational siRNA design for RNA interference. Nat Biotechnol 2004; 22: 326–330. ArticleCASPubMed Google Scholar
Chang L-J, Zaiss A-K . Methods for the preparation and use of lentivirus vectors. In: Morgan J (ed). Gene Therapy Protocols. Humana Press Inc.: Totowa, NJ, 2001, pp 303–318. Chapter Google Scholar
Schramke V, Allshire R . Hairpin RNAs and retrotransposon LTRs effect RNAi and chromatin-based gene silencing. Science 2003; 301: 1069–1074. ArticleCASPubMed Google Scholar
Volpe TA et al. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 2002; 297: 1833–1837. ArticleCASPubMed Google Scholar
Sijen T, Plasterk RH . Transposon silencing in the Caenorhabditis elegans germ line by natural RNAi. Nature 2003; 426: 310–314. ArticleCASPubMed Google Scholar
Chang L-J, Zhang C . Infection and replication of Tat-minus human immunodeficiency viruses: genetic analyses of LTR and tat mutants in primary and long-term human lymphoid cells. Virology 1995; 211: 157–169. ArticleCASPubMed Google Scholar
Tremblay M et al. New CD4(+) cell line susceptible to infection by HIV-1. J Med Virol 1989; 28: 243–249. ArticleCASPubMed Google Scholar
Zaiss A-K, Son S, Chang L-J . RNA 3′-readthrough of oncoretrovirus and lentivirus: implications in vector safety and efficacy. J Virol 2002; 76: 7209–7219. ArticleCASPubMedPubMed Central Google Scholar
Kimpton J, Emerman M . Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol 1992; 66: 2232–2239. CASPubMedPubMed Central Google Scholar